RADNOR, Pa., Aug. 17, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors about a securities class action lawsuit filed in the United States District Court for the District of Maryland against MacroGenics, Inc. (“MacroGenics”) ( NASDAQ: MGNX ) on behalf of investors who purchased MacroGenics stock or sold MacroGenics puts between March 7, 2024, and May 9, 2024 (the “Class Period”). The lead plaintiff deadline is September 24, 2024.

CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you experienced losses with MacroGenics, you may CLICK HERE or visit: https://www.ktmc.com/new-cases/macrogenics-in...amp;mktm=r

You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at info@ktmc.com .

Please CLICK HERE to view our video or copy and paste this link into your browser: https://youtu.be/toOTecvIuus

DEFENDANTS’ ALLEGED MISCONDUCT: The complaint alleges that, during the Class Period, Defendants made false and/or misleading statements about the company’s TAMARACK Phase 2 study of its drug vobramitamab duocarmazine (vobra duo) in patients with resistant prostate cancer. The complaint asserts that Defendants’ statements created a misleading impression about the safety profile of vobra duo and the overall data from the Phase 2 TAMARACK study.

THE LEAD PLAINTIFF PROCESS: MacroGenics investors may, no later than September 24, 2024, seek appointment as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors with the largest financial interest and who are adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class, and these attorneys, if approved by the court, serve as lead or class counsel. Your ability to share in any recovery is not affected by whether or not you serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP encourages MacroGenics investors who have suffered significant losses to contact the firm directly for more information.

CLICK HERE TO SIGN UP FOR THE CASE OR VISIT : https://www.ktmc.com/new-cases/macrogenics-in...amp;mktm=r

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:      

Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts across the U.S. and globally. The firm has built a worldwide reputation for excellence, recovering billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees, and others from fraud, abuse, misconduct, and negligence by businesses and fiduciaries. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP , please visit www.ktmc.com .

CONTACT:

Kessler Topaz Meltzer & Check, LLP Jonathan Naji, Esq. (484) 270-1453 280 King of Prussia Road Radnor, PA 19087 info@ktmc.com

May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.